Stocks · Healthcare · Drug Manufacturers - General
Johnson & Johnson JNJ
$256.03 -1.02% Close, Oct 2, 2026 · NYSE · Market cap $617.01B
High qualityLow risk
Next earnings report: Oct 13, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- The shares trade at 29.7× trailing earnings, higher than 86% of the company's own readings over the past five years.
- The stock is in an uptrend: above its 200-day average for 307 trading days, with the 50-day average above the 200-day.
- Revenue over the last four quarters was $97.93B, up 8.1% from a year earlier.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
Growth43Weak
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 48%
- EPS growth (TTM, YoY)Bottom 40%
- FCF growth (TTM, YoY)Top 46%
- Revenue growth, 3-year CAGRBottom 39%
- Revenue growth accelerationTop 43%
Quality83Strong
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 9%
- Gross marginTop 46%
- Operating marginTop 9%
- Cash conversion (OCF / net income)Bottom 26%
- Accruals (lower is better)Bottom 20%
- Net debt / EBITDA (lower is better)Top 45%
- Interest coverTop 7%
Value64Neutral
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 16%
- Free-cash-flow yieldTop 26%
- EBITDA / enterprise valueTop 22%
- Sales / enterprise valueBottom 41%
- P/E vs own 5-year history (lower is better)Bottom 15%
Momentum69Positive
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 35%
- 6-month returnBottom 48%
- 1-year return vs S&P 500Top 31%
- Distance from 52-week highTop 14%
- Trend checklist (0–4)Top 39%
Revisions18Very weak
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 44%
- Consecutive EPS beatsTop 35%
- Share of analysts rating BuyBottom 18%
- Upside to consensus price targetBottom 20%
Stability99Exceptional
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 1%
- Maximum drawdown, 3 yearsTop 1%
- Beta vs S&P 500 (lower is better)Top 3%
- Net debt / EBITDA (lower is better)Top 45%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 7.9% | 8.1% | ↑ |
| EPS growth (YoY) | -3.8% | -7.7% | ↓ |
| Gross margin | 67.9% | 67.9% | ↓ |
| Operating margin | 24.5% | 26.8% | ↑ |
| FCF margin | 18.1% | 19.1% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 8.1% | 7.9% | ↑ | Bottom 48% |
| EPS growth (TTM, YoY) | -7.7% | -3.8% | ↓ | Bottom 40% |
| Gross margin | 67.9% | 67.9% | ↓ | Top 46% |
| Operating margin | 26.8% | 24.5% | ↑ | Top 9% |
| Net margin | 21.5% | 25.0% | ↓ | — |
| Free-cash-flow margin | 19.1% | 18.1% | ↑ | — |
| Return on invested capital | 13.9% | — | Top 9% | |
| Revenue growth, 3-year CAGR | 5.6% | — | Bottom 39% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 1.13×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -1.3%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 1.4%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -1.3 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 0.85×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 25.9×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 2.05%
- Net buyback yield (TTM)
- 0.85%
- Shareholder yield
- 2.89%
- Share count change, 1 year
- +0.9%
- Share count change, 3-year CAGR
- -2.4%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 28, 2026 (filed Jul 23, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 2
- Beats in the last 8 reports
- 7 of 8
- Average EPS surprise, last 4
- +1.1%
- Average 2-day reaction, last 8
- +0.4%
- Positive 20 days after report
- 4 of 8
Analysts
- Consensus price target
- $286.33
- Target vs current price
- +11.8%
- Analysts with a rating
- 40
- Share rating Buy or Strong Buy
- 53%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Jul 15, 2026 | +2.1% | -2.7% | -1.3% | +2.3% | — |
| Apr 14, 2026 | +0.7% | +0.9% | -3.1% | -6.9% | +8.9% |
| Jan 21, 2026 | +0.0% | -0.1% | +2.9% | +12.3% | +7.5% |
| Oct 14, 2025 | +1.4% | -0.0% | +1.5% | -1.3% | +7.8% |
| Jul 16, 2025 | +3.4% | +6.2% | +8.2% | +11.3% | +22.2% |
| Apr 15, 2025 | +7.4% | -0.5% | +2.2% | -3.8% | +1.6% |
| Jan 22, 2025 | +2.5% | -1.9% | +1.5% | +6.6% | +3.9% |
| Oct 15, 2024 | +9.5% | +1.5% | +0.8% | -4.1% | -12.1% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Jul 15, 2026 | $2.90 | $2.84 | +2.1% | $25.31B |
| Apr 14, 2026 | $2.70 | $2.68 | +0.7% | $24.06B |
| Jan 21, 2026 | $2.46 | $2.46 | +0.0% | $24.56B |
| Oct 14, 2025 | $2.80 | $2.76 | +1.4% | $23.99B |
| Jul 16, 2025 | $2.77 | $2.68 | +3.4% | $23.74B |
| Apr 15, 2025 | $2.77 | $2.58 | +7.4% | $21.89B |
| Jan 22, 2025 | $2.04 | $1.99 | +2.5% | $22.52B |
| Oct 15, 2024 | $2.42 | $2.21 | +9.5% | $22.47B |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 29.7× | 24.0× | 86th | Top 16% |
| P/E (forward) | 22.4× | — | — | — |
| EV / EBITDA | 19.1× | — | — | Top 22% |
| EV / Sales | 6.59× | — | — | Bottom 41% |
| Free-cash-flow yield | 3.03% | — | — | Top 26% |
| Earnings yield | 3.37% | — | — | Top 16% |
P/E over the past five years
Range 10.0× – 34.3× since Jul 4, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- +37.6%
- Earnings per share growth (TTM)
- -7.7%
- Change in P/E multiple
- +65.7%
Most of the move came from a change in the valuation multiple.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 307
- 50-day average slope (20 days)
- +1.9%
- 200-day average slope (20 days)
- +2.7%
- Distance from 50-day average
- -3.7%
- Distance from 200-day average
- +5.9%
- RSI (14)
- 32.3
- Relative volume
- 1.73×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 20.3%
- Volatility vs own 5-year history
- 87th percentile · High for this stock
- Beta vs S&P 500 (2 years, weekly)
- -0.02
- Correlation with S&P 500
- -0.01
- Current drawdown from 1-year high
- -8.0%
- Maximum drawdown, 3 years
- -15.1%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Apr 25, 2022 | Jan 10, 2025 | -23.6% | 681 days | 181 days (Oct 1, 2025) |
| Aug 17, 2021 | Nov 30, 2021 | -13.1% | 73 days | 83 days (Mar 30, 2022) |
| Mar 2, 2026 | May 8, 2026 | -11.0% | 48 days | 33 days (Jun 26, 2026) |
| Jan 26, 2021 | Mar 4, 2021 | -10.2% | 26 days | 54 days (May 20, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $617.01B
- P/E (TTM)
- 29.7
- EPS, diluted (TTM)
- $8.63
- Revenue (TTM)
- $97.93B
- Dividend yield
- 2.06%
- 52-week range
- $182.94 – $281.07
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $78.74B | $79.99B | $85.16B | $88.82B | $94.19B |
| Gross profit | $55.34B | $55.39B | $58.61B | $61.35B | $63.94B |
| Operating income | $20.94B | $21.01B | $23.41B | $22.15B | $25.60B |
| Net income | $20.88B | $17.94B | $35.15B | $14.07B | $26.80B |
| EPS (diluted) | $7.81 | $6.73 | $13.72 | $5.79 | $11.03 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $22.47B | $22.52B | $21.89B | $23.74B | $23.99B | $24.56B | $24.06B | $25.31B |
| Net income | $2.69B | $3.43B | $11.00B | $5.54B | $5.15B | $5.12B | $5.24B | $5.53B |
| EPS (diluted) | $1.11 | $1.41 | $4.54 | $2.29 | $2.12 | $2.10 | $2.14 | $2.27 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $23.41B | $21.19B | $22.79B | $24.27B | $24.53B |
| Capital expenditure | -$3.65B | -$4.01B | -$4.54B | -$4.42B | -$4.83B |
| Free cash flow | $19.76B | $17.18B | $18.25B | $19.84B | $19.70B |
| Dividends paid | -$11.03B | -$11.68B | -$11.77B | -$11.82B | -$12.38B |
| Net share buybacks | -$3.46B | -$6.04B | -$813.0M | -$2.43B | -$5.95B |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $20.76B
- Total assets
- $201.06B
- Total liabilities
- $116.09B
- Total debt
- $49.04B
- Net debt
- $28.61B
- Shareholders’ equity
- $84.97B
As of Jun 28, 2026 (filed Jul 23, 2026).
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| Aug 25, 2026 | $1.34 | Sep 8, 2026 |
| May 26, 2026 | $1.34 | Jun 9, 2026 |
| Feb 24, 2026 | $1.30 | Mar 10, 2026 |
| Nov 25, 2025 | $1.30 | Dec 9, 2025 |
| Aug 26, 2025 | $1.30 | Sep 9, 2025 |
| May 27, 2025 | $1.30 | Jun 10, 2025 |
| Feb 18, 2025 | $1.24 | Mar 4, 2025 |
| Nov 26, 2024 | $1.24 | Dec 10, 2024 |
Short interest
- Shares sold short
- 21,188,522
- Days to cover
- 3.65
- Change vs previous report
- -2.2%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Jun 13, 2001
- 2-for-1
- Jun 12, 1996
- 2-for-1
- Jun 10, 1992
- 2-for-1
- May 11, 1989
- 2-for-1
- May 19, 1981
- 3-for-1